Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
Holobiome has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Holobiome's investors include Valor Equity Partners, Astanor Ventures, iSelect Fund, Able Partners, Satori Capital.
Holobiome is headquartered in Cambridge, United States.
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
Holobiome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Holobiome — Funding & Investors." VCBacked, July 22, 2026, https://www.vcbacked.co/company/holobiome. Accessed September 14, 2026.
VCBacked. (2026). Holobiome — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/holobiome
{{cite web |title=Holobiome — Funding & Investors |url=https://www.vcbacked.co/company/holobiome |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated